Skip to Main content Skip to Navigation
Journal articles

TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study

Abstract : In this study, the authors report the case of a patient diagnosed with hepatitis C virus who was treated with sofosbuvir-velpatasvir (400/100 mg). As the patient was unable to swallow whole tablets, therapeutic drug monitoring was performed to evaluate the effect of crushing sofosbuvir-velpatasvir tablets on drug absorption and global exposure.
Complete list of metadata

Cited literature [7 references]  Display  Hide  Download
Contributor : Laurent Jonchère Connect in order to contact the contributor
Submitted on : Wednesday, February 12, 2020 - 2:56:31 PM
Last modification on : Wednesday, March 30, 2022 - 2:40:20 PM
Long-term archiving on: : Wednesday, May 13, 2020 - 4:35:19 PM


Lalanne et al-2019-TDM-guided ...
Files produced by the author(s)



Sébastien Lalanne, Caroline Jezequel, Camille Tron, Marie-Clémence Verdier, Marion Mercerolle, et al.. TDM-guided Crushed Sofosbuvir-velpatasvir Treatment: A case study. Therapeutic Drug Monitoring, Lippincott, Williams & Wilkins, 2020, 42 (2), pp.163-164. ⟨10.1097/FTD.0000000000000718⟩. ⟨hal-02440785⟩



Record views


Files downloads